Article
Genomic and Serological Rheumatoid Arthritis Biomarkers, MUC5B Promoter Variant, and Interstitial Lung Abnormalities.
Annals of the American Thoracic Society - 1 Jan 2025
Kim John S, Flack Kathryn F, Malik Vidhi, Manichaikul Ani, Sakaue Saori, Luo Yang, McGroder Claire F, Salvatore Mary, Anderson Michaela R, Hoffman Eric A, Podolanczuk Anna J, Yun Jae Hee, McDermott Gregory C, Sparks Jeffrey A, Putman Rachel, Moll Matthew, Rich Stephen S, Rotter Jerome I, Noth Imre, Raghu Ganesh, Giles Jon T, Winchester Robert, Raychaudhuri Soumya, Hunninghake Gary M, Cho Michael H, Garcia Christine Kim, Barr R Graham, Bernstein Elana J
Abstract excerpt
Rationale: Rheumatoid arthritis (RA) has been implicated in interstitial lung disease, as the majority of studies have comprised patients with known RA. However, it remains unclear whether an underlying risk for RA in combination with genetic risk for pulmonary fibrosis is associated with radiological markers of early lung injury and fibrosis in broader population samples. Objective: We sought to determine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
